CALCA and prostate carcinoma: Calcitonin also causes adverse effects, such as hypocalcemia, nasal adverse reactions, formation of calcitonin antibodies, and prostate cancer (Tabatabaei-Malazy et al., 2017; Akkawi and Zmerly, 2018).